TGA provisionally approves Pfizer COVID-19 vaccine

TGA

25 January 2021 - The Therapeutic Goods Administration has granted provisional approval to Pfizer Australia for its COVID-19 vaccine, Comirnaty, making it the first COVID-19 vaccine to receive regulatory approval in Australia.

Following a thorough and independent review of Pfizer's submission, the TGA has decided that this vaccine meets the high safety, efficacy and quality standards required for use in Australia.

Read TGA News

Michael Wonder

Posted by:

Michael Wonder